Oxford Biomedica has signed a new Commercial Supply Agreement with Bristol Myers Squibb for the manufacture and supply of lentiviral vectors for CAR-T programmes...
SSE plc reports strong Q3 performance for the nine months to 31 December 2025, with a 64% increase in regulated networks investment and renewable output up 7% year on year...
GSK delivered a strong financial performance in 2025, with sales of £32.7 billion driven by double-digit growth in Specialty Medicines across Respiratory, Immunology & Inflammation, Oncology and HIV...
DCC plc reported strong adjusted operating profit growth in the third quarter ended 31 December 2025, driven by good organic performance and the first contribution from recent acquisitions...
Cizzle Biotechnology has been granted Canadian patent protection for methods measuring the CIZ1B lung cancer biomarker, strengthening its intellectual property portfolio...
Gervais Williams discusses how Arbuthnot Banking Group’s rising funds under management, deposit growth, and cautious lending strategy contribute to sustainable earnings and dividend potential, positioning the £142m bank as an overlooked opportunity in the UK financial sector...
Tech-led gains and calmer metals trading lifted Asian markets, as investors repositioned around a rebound in risk sentiment and a firmer global economic backdrop...
Plus500 has launched event-based contracts on its US B2C platform, Plus500 Futures, marking its entry into the regulated US retail prediction markets segment...
Kingfisher plc has announced the appointment of Stephen Daintith to its Board as a Non-Executive Director and member of the Audit and Nomination Committees, effective 1 April 2026...
CQS Natural Resources Growth and Income has published a circular convening a general meeting on 2 March 2026, at which shareholders will be asked to approve new authorities to issue up to 20 per cent. of the Company’s issued share capital on a non pre-emptive basis...
Quadrise plc announces the release of its Sustainability Report 2025, reporting a 21% reduction in operational emissions intensity, successful engine trials of MSAR® and bioMSAR™, and continued progress toward commercial deployment across shipping and international energy projects...
Oxford Biomedica has signed a new Commercial Supply Agreement with Bristol Myers Squibb for the manufacture and supply of lentiviral vectors for CAR-T programmes...
SSE plc reports strong Q3 performance for the nine months to 31 December 2025, with a 64% increase in regulated networks investment and renewable output up 7% year on year...
GSK delivered a strong financial performance in 2025, with sales of £32.7 billion driven by double-digit growth in Specialty Medicines across Respiratory, Immunology & Inflammation, Oncology and HIV...
DCC plc reported strong adjusted operating profit growth in the third quarter ended 31 December 2025, driven by good organic performance and the first contribution from recent acquisitions...
Cizzle Biotechnology has been granted Canadian patent protection for methods measuring the CIZ1B lung cancer biomarker, strengthening its intellectual property portfolio...
Gervais Williams discusses how Arbuthnot Banking Group’s rising funds under management, deposit growth, and cautious lending strategy contribute to sustainable earnings and dividend potential, positioning the £142m bank as an overlooked opportunity in the UK financial sector...
Tech-led gains and calmer metals trading lifted Asian markets, as investors repositioned around a rebound in risk sentiment and a firmer global economic backdrop...
Plus500 has launched event-based contracts on its US B2C platform, Plus500 Futures, marking its entry into the regulated US retail prediction markets segment...
Kingfisher plc has announced the appointment of Stephen Daintith to its Board as a Non-Executive Director and member of the Audit and Nomination Committees, effective 1 April 2026...
CQS Natural Resources Growth and Income has published a circular convening a general meeting on 2 March 2026, at which shareholders will be asked to approve new authorities to issue up to 20 per cent. of the Company’s issued share capital on a non pre-emptive basis...
Quadrise plc announces the release of its Sustainability Report 2025, reporting a 21% reduction in operational emissions intensity, successful engine trials of MSAR® and bioMSAR™, and continued progress toward commercial deployment across shipping and international energy projects...
